Recent News

March 23, 2021

scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

Read More
February 25, 2021

scPharmaceuticals to Present in Two Upcoming Investor Conferences

Read More
February 23, 2021

scPharmaceuticals Inc. Announces Results of Type A End-of-Review Meeting with FDA Regarding FUROSCIX® NDA

Read More
February 17, 2021

scPharmaceuticals Inc. Appoints Renowned Heart Failure Specialist William T. Abraham, M.D., to its Board of Directors

Read More